NO742255L - - Google Patents
Info
- Publication number
- NO742255L NO742255L NO742255A NO742255A NO742255L NO 742255 L NO742255 L NO 742255L NO 742255 A NO742255 A NO 742255A NO 742255 A NO742255 A NO 742255A NO 742255 L NO742255 L NO 742255L
- Authority
- NO
- Norway
- Prior art keywords
- acid
- acetone
- salt
- ammonium
- reaction
- Prior art date
Links
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 211
- 238000000034 method Methods 0.000 claims description 99
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 63
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 41
- JWUXJYZVKZKLTJ-UHFFFAOYSA-N Triacetonamine Chemical compound CC1(C)CC(=O)CC(C)(C)N1 JWUXJYZVKZKLTJ-UHFFFAOYSA-N 0.000 claims description 40
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 36
- 239000002253 acid Substances 0.000 claims description 29
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical group CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 claims description 28
- -1 nitrogen-containing organic base Chemical class 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 19
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 18
- 235000019270 ammonium chloride Nutrition 0.000 claims description 18
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 18
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 17
- 229910021529 ammonia Inorganic materials 0.000 claims description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 14
- CQTRUFMMCCOKTA-UHFFFAOYSA-N 4-amino-4-methylpentan-2-one Chemical compound CC(=O)CC(C)(C)N CQTRUFMMCCOKTA-UHFFFAOYSA-N 0.000 claims description 12
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 12
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 12
- OZXIZRZFGJZWBF-UHFFFAOYSA-N 1,3,5-trimethyl-2-(2,4,6-trimethylphenoxy)benzene Chemical group CC1=CC(C)=CC(C)=C1OC1=C(C)C=C(C)C=C1C OZXIZRZFGJZWBF-UHFFFAOYSA-N 0.000 claims description 10
- SHOJXDKTYKFBRD-UHFFFAOYSA-N mesityl oxide Chemical group CC(C)=CC(C)=O SHOJXDKTYKFBRD-UHFFFAOYSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 229910015900 BF3 Inorganic materials 0.000 claims description 9
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 9
- 239000003054 catalyst Substances 0.000 claims description 8
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 7
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000004202 carbamide Substances 0.000 claims description 6
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims description 6
- FTVFPPFZRRKJIH-UHFFFAOYSA-N 2,2,6,6-tetramethylpiperidin-4-amine Chemical compound CC1(C)CC(N)CC(C)(C)N1 FTVFPPFZRRKJIH-UHFFFAOYSA-N 0.000 claims description 5
- 239000002841 Lewis acid Substances 0.000 claims description 5
- 239000003377 acid catalyst Substances 0.000 claims description 5
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloro-acetic acid Natural products OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 claims description 5
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 claims description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 5
- 150000007517 lewis acids Chemical class 0.000 claims description 5
- 239000011707 mineral Substances 0.000 claims description 5
- 235000010755 mineral Nutrition 0.000 claims description 5
- MTZWHHIREPJPTG-UHFFFAOYSA-N phorone Chemical compound CC(C)=CC(=O)C=C(C)C MTZWHHIREPJPTG-UHFFFAOYSA-N 0.000 claims description 5
- 229930193351 phorone Natural products 0.000 claims description 5
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 4
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims description 4
- 229940092714 benzenesulfonic acid Drugs 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 4
- 229940071870 hydroiodic acid Drugs 0.000 claims description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 4
- HSZCZNFXUDYRKD-UHFFFAOYSA-M lithium iodide Chemical compound [Li+].[I-] HSZCZNFXUDYRKD-UHFFFAOYSA-M 0.000 claims description 4
- IIPYXGDZVMZOAP-UHFFFAOYSA-N lithium nitrate Chemical compound [Li+].[O-][N+]([O-])=O IIPYXGDZVMZOAP-UHFFFAOYSA-N 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 229910017604 nitric acid Inorganic materials 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 3
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 3
- 229930016911 cinnamic acid Natural products 0.000 claims description 3
- 235000013985 cinnamic acid Nutrition 0.000 claims description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 3
- 239000011976 maleic acid Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 3
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 2
- ZRXHLJNBNWVNIM-UHFFFAOYSA-N 3-methyl-1-benzofuran Chemical compound C1=CC=C2C(C)=COC2=C1 ZRXHLJNBNWVNIM-UHFFFAOYSA-N 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- 229910002651 NO3 Inorganic materials 0.000 claims description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 2
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 claims description 2
- 229940077388 benzenesulfonate Drugs 0.000 claims description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 229960005215 dichloroacetic acid Drugs 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 235000009518 sodium iodide Nutrition 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 150000003863 ammonium salts Chemical class 0.000 claims 6
- MLIREBYILWEBDM-UHFFFAOYSA-N cyanoacetic acid Chemical compound OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 claims 6
- 150000007524 organic acids Chemical class 0.000 claims 6
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 claims 3
- XMVQMBLTFKAIOX-UHFFFAOYSA-N 6-azaniumylhexylazanium;dichloride Chemical compound [Cl-].[Cl-].[NH3+]CCCCCC[NH3+] XMVQMBLTFKAIOX-UHFFFAOYSA-N 0.000 claims 2
- 230000002378 acidificating effect Effects 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- 229940074355 nitric acid Drugs 0.000 claims 2
- ZXNWYMNKYXUZGM-UHFFFAOYSA-N 2,2,6,6-tetramethylpiperidin-1-ium-4-one;chloride Chemical compound Cl.CC1(C)CC(=O)CC(C)(C)N1 ZXNWYMNKYXUZGM-UHFFFAOYSA-N 0.000 claims 1
- XZXYQEHISUMZAT-UHFFFAOYSA-N 2-[(2-hydroxy-5-methylphenyl)methyl]-4-methylphenol Chemical compound CC1=CC=C(O)C(CC=2C(=CC=C(C)C=2)O)=C1 XZXYQEHISUMZAT-UHFFFAOYSA-N 0.000 claims 1
- ZKZAMHIUFAHSIB-UHFFFAOYSA-N 4-methylbenzenesulfonic acid;urea Chemical compound NC(N)=O.CC1=CC=C(S(O)(=O)=O)C=C1 ZKZAMHIUFAHSIB-UHFFFAOYSA-N 0.000 claims 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 claims 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims 1
- 229940107816 ammonium iodide Drugs 0.000 claims 1
- UYJXRRSPUVSSMN-UHFFFAOYSA-P ammonium sulfide Chemical compound [NH4+].[NH4+].[S-2] UYJXRRSPUVSSMN-UHFFFAOYSA-P 0.000 claims 1
- GDCXBZMWKSBSJG-UHFFFAOYSA-N azane;4-methylbenzenesulfonic acid Chemical compound [NH4+].CC1=CC=C(S([O-])(=O)=O)C=C1 GDCXBZMWKSBSJG-UHFFFAOYSA-N 0.000 claims 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 claims 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 claims 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 claims 1
- HAPIXNBOBZHNCA-UHFFFAOYSA-N methyl 4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate Chemical compound COC(=O)C1=CC=C(C)C(B2OC(C)(C)C(C)(C)O2)=C1 HAPIXNBOBZHNCA-UHFFFAOYSA-N 0.000 claims 1
- QHDUJTCUPWHNPK-UHFFFAOYSA-N methyl 7-methoxy-2h-indazole-3-carboxylate Chemical compound COC1=CC=CC2=C(C(=O)OC)NN=C21 QHDUJTCUPWHNPK-UHFFFAOYSA-N 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 13
- 229920006395 saturated elastomer Polymers 0.000 description 11
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 125000001931 aliphatic group Chemical group 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000012230 colorless oil Substances 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000012429 reaction media Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- PIFBMJMXJMZZRG-UHFFFAOYSA-N 2,2,4,6,6-pentamethyl-1,5-dihydropyrimidine Chemical compound CC1=NC(C)(C)NC(C)(C)C1 PIFBMJMXJMZZRG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- GDJQNGMJGMABLV-UHFFFAOYSA-N 1,3,3,4-tetramethylpiperidin-2-one Chemical compound CC1CCN(C)C(=O)C1(C)C GDJQNGMJGMABLV-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 239000004135 Bone phosphate Substances 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- ZGSDJMADBJCNPN-UHFFFAOYSA-N [S-][NH3+] Chemical compound [S-][NH3+] ZGSDJMADBJCNPN-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LHXCUWOJEALYLZ-BTJKTKAUSA-N (z)-but-2-enedioic acid;morpholine Chemical compound C1COCCN1.OC(=O)\C=C/C(O)=O LHXCUWOJEALYLZ-BTJKTKAUSA-N 0.000 description 1
- BGBNXIKULUCCOO-BTJKTKAUSA-N (z)-but-2-enedioic acid;n,n-diethylethanamine Chemical compound CCN(CC)CC.OC(=O)\C=C/C(O)=O BGBNXIKULUCCOO-BTJKTKAUSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
- UJJKZUADXRRRIB-UHFFFAOYSA-N 1,2,2,3,4-pentamethyl-4h-pyrimidine Chemical compound CC1C=CN(C)C(C)(C)N1C UJJKZUADXRRRIB-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- ZQXCQTAELHSNAT-UHFFFAOYSA-N 1-chloro-3-nitro-5-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 ZQXCQTAELHSNAT-UHFFFAOYSA-N 0.000 description 1
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- CJNZAXGUTKBIHP-UHFFFAOYSA-N 2-iodobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1I CJNZAXGUTKBIHP-UHFFFAOYSA-N 0.000 description 1
- NJBCRXCAPCODGX-UHFFFAOYSA-N 2-methyl-n-(2-methylpropyl)propan-1-amine Chemical compound CC(C)CNCC(C)C NJBCRXCAPCODGX-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- CJZGXWURAFVFND-UHFFFAOYSA-N 4-hydroxy-4-oxobutanoate;triethylazanium Chemical compound CCN(CC)CC.OC(=O)CCC(O)=O CJZGXWURAFVFND-UHFFFAOYSA-N 0.000 description 1
- KDVYCTOWXSLNNI-UHFFFAOYSA-N 4-t-Butylbenzoic acid Chemical compound CC(C)(C)C1=CC=C(C(O)=O)C=C1 KDVYCTOWXSLNNI-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- QLZHNIAADXEJJP-UHFFFAOYSA-N Phenylphosphonic acid Chemical compound OP(O)(=O)C1=CC=CC=C1 QLZHNIAADXEJJP-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- MQFIKAWTCOXAAY-UHFFFAOYSA-N acetic acid;n-butylbutan-1-amine Chemical compound CC([O-])=O.CCCC[NH2+]CCCC MQFIKAWTCOXAAY-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- AOYBHNPXSFAWHT-UHFFFAOYSA-N butanedioic acid;morpholine Chemical compound C1COCCN1.OC(=O)CCC(O)=O AOYBHNPXSFAWHT-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 239000003426 co-catalyst Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- VHMQVZZBBWVYLF-UHFFFAOYSA-N cyclohexanamine;formic acid Chemical compound [O-]C=O.[NH3+]C1CCCCC1 VHMQVZZBBWVYLF-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- SLOGLADXVJGNQE-UHFFFAOYSA-N dibutylazanium;benzoate Chemical compound CCCCNCCCC.OC(=O)C1=CC=CC=C1 SLOGLADXVJGNQE-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229940013688 formic acid Drugs 0.000 description 1
- FDTUVFSBEYKVAP-UHFFFAOYSA-N formic acid;pyridine Chemical compound OC=O.C1=CC=NC=C1 FDTUVFSBEYKVAP-UHFFFAOYSA-N 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- GPSDUZXPYCFOSQ-UHFFFAOYSA-N m-toluic acid Chemical compound CC1=CC=CC(C(O)=O)=C1 GPSDUZXPYCFOSQ-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 150000005209 naphthoic acids Chemical class 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- FHSWXOCOMAVQKE-UHFFFAOYSA-N phenylazanium;acetate Chemical compound CC([O-])=O.[NH3+]C1=CC=CC=C1 FHSWXOCOMAVQKE-UHFFFAOYSA-N 0.000 description 1
- MLCHBQKMVKNBOV-UHFFFAOYSA-N phenylphosphinic acid Chemical compound OP(=O)C1=CC=CC=C1 MLCHBQKMVKNBOV-UHFFFAOYSA-N 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- USPWKWBDZOARPV-UHFFFAOYSA-N pyrazolidine Chemical compound C1CNNC1 USPWKWBDZOARPV-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 229960004319 trichloroacetic acid Drugs 0.000 description 1
- AVBGNFCMKJOFIN-UHFFFAOYSA-N triethylammonium acetate Chemical compound CC(O)=O.CCN(CC)CC AVBGNFCMKJOFIN-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
Description
Fremgangsmåte til fremstilling av Method for the production of
2,2,6,6-tetrametyl-4-oksopiperidin.2,2,6,6-tetramethyl-4-oxopiperidine.
Fremstillingen av 2,2,6,6-tetrametyl-4-oksopiperidinThe preparation of 2,2,6,6-tetramethyl-4-oxopiperidine
er kjent. Den består i at man omsetter 2,2,4,4,6-pentametyl-2,3,4,5-tetrahydropyrimidin med en Lewissyre, fortrinnsvis sinkklorid eller kalsiumklorid i nærvær av vann. Dette som utgangsmaterial anvendbare pyrimidinderivat er fremstillbart fra aceton og ammoniakk, dets isolering fra reaksjonsmediet samt eventuell rensning krever imidlertid komplisert arbeide. is known. It consists in reacting 2,2,4,4,6-pentamethyl-2,3,4,5-tetrahydropyrimidine with a Lewis acid, preferably zinc chloride or calcium chloride in the presence of water. This pyrimidine derivative, which can be used as a starting material, can be prepared from acetone and ammonia, but its isolation from the reaction medium and possible purification require complicated work.
Det er også allerede forsøkt'å forene begge reaksjons-trinn, dvs. å realisere fremstillingen av 2 ,2,6,6-tetrametyl-4-okso-piperidin direkte fra aceton, uten isolering av pentametyltetrahydro-pyrimidinet. Tilsvarende forsøk medførte hittil ingen tilfredsstil-lende utbytter, det oppsto reaksjonsblandinger hvis adskillelse er Attempts have also already been made to combine both reaction steps, i.e. to realize the production of 2,2,6,6-tetramethyl-4-oxo-piperidine directly from acetone, without isolation of the pentamethyltetrahydropyrimidine. Corresponding attempts have so far resulted in no satisfactory yields, resulting in reaction mixtures whose separation is
vanskelig og taprik.difficult and difficult.
Det er nå overraskende funnet at man under overholdelse av bestemte fremgangsmåtebetingelser direkte fra aceton kan frem-stille 2,2,6,6-tetrametyl-4-oksopiperidin i gode utbytter og renhet. Fremgangsmåten består av to fremgangsmåtetrinn som er gjennomførbart umiddelbart etter hverandre således at den fremfor alt egner seg for storteknisk fremstilling av tetrametylpiperidon. Fremgangsmåten ifølge oppfinnelsen erkarakterisert vedat man a) omsetter aceton med ammoniakk i nærvær av 0,2 til 12 mol% s referert til anvendt aceton, av en sur katalysator ved 5 til 60°C og b) fullstendiggjør reaksjonen med eller uten tilsetning av ytterligere aceton ved ytterligere oppvarmning, idet den samlede mengde av det i reaksjonen anvendte aceton står i et molart forhold til anvendt mengde ammoniakk fra lik eller større enn 1,6:1. It has now surprisingly been found that, subject to certain process conditions, 2,2,6,6-tetramethyl-4-oxopiperidine can be produced directly from acetone in good yields and purity. The method consists of two process steps which can be carried out immediately one after the other so that it is above all suitable for large-scale production of tetramethylpiperidone. The method according to the invention is characterized by a) reacting acetone with ammonia in the presence of 0.2 to 12 mol%, referred to the acetone used, of an acid catalyst at 5 to 60°C and b) completing the reaction with or without the addition of further acetone by further heating, the total amount of acetone used in the reaction being in a molar ratio to the amount of ammonia used from equal to or greater than 1.6:1.
I første trinn av fremgangsmåten lar man fortrinnsvis minst 0,15 mol ammoniakk reagere- méd aceton, men av praktiske grunner er det mere hensiktsmessig å mette reaksjonsblandingen med ammoniakk, derfor foretrekkes et ammoniakkoverskudd. In the first step of the method, preferably at least 0.15 mol of ammonia is allowed to react with acetone, but for practical reasons it is more appropriate to saturate the reaction mixture with ammonia, therefore an excess of ammonia is preferred.
Som katalysator kan det enten anvendes en Lewissyre,As a catalyst, either a Lewis acid can be used,
som f.eks. aluminiumklorid, tinntetraklorid eller fortrinnsvis bortrifluorid resp. et bortrifluoridaddukt; eller man anvender en protonsyre eller et salt av en protonsyre med ammoniakk eller en nitrogenholdig organisk base, spesielt en primær, sekundær.eller tertiær nitrogenbase. like for example. aluminum chloride, tin tetrachloride or preferably boron trifluoride or a boron trifluoride adduct; or one uses a proton acid or a salt of a proton acid with ammonia or a nitrogen-containing organic base, especially a primary, secondary or tertiary nitrogen base.
Eksempler for slike protonsyrer resp. for syrekomponent-ene i salter anvendt som syrekatalysatorer er spesielt mineralsyrer som saltsyre, bromhydrogensyre, jodhydrogensyre, salpetersyre, svovelsyre og fosforsyre, samt sulfonsyrer, som alifatiske eller aromatiske sulfonsyrer, f.eks. metansulfonsyre, benzensulfonsyre, p-toluensulfonsyre eller naftalinsulfonsyre, fosfonsyrer eller fosfinsyrer, som alifatiske eller aromatiske, f.eks. metyl-, benzyl- eller fenylfosfon-syre, eller dimetyl-, dietyl- eller fenylfosfinsyre og karboksylsyrer som enbasiske, tobasiske eller trebasiske alifatiske eller aromatiske karboksylsyrer, f.eks. mettede eller umettede enbasiske alifatiske karboksylsyrer med 1-18 C-atomer, som maursyre, eddiksyre, kloreddik-syre, dikloreddiksyre, trikloreddiksyre, propionsyre, smørsyre, lau-rinsyre, palmitinsyre, stearinsyre, akrylsyre, metakrylsyre og kanelsyre, mettede og umettede tobasiske alifatiske karboksylsyrer som oksalsyre, malonsyre, ravsyre, adipinsyre, sebacinsyre, vinsyre, eplesyre, fumarsyre og maleinsyre, trebasiske alifatiske karboksyl syrer som sitronsyre, enbasiske aromatiske karboksylsyrer som eventuelt substituerte benzosyrer og naftosyrer og tobasiske aromatiske karboksylsyrer som ftalsyre og tereftalsyre. Foretrukket er enbasiske og tobasiske, alifatiske eller aromatiske karboksylsyrer og enbasiske aromatiske sulfonsyrer, som eddiksyre, ravsyre, maleinsyre, benzosyre, o-jodbenzosyre , m-metylbenzosyre , p-tert.-butylbenzo-syre, p-toluensulfonsyre og kanelsyre. Som organiske baser er det egnet: alifatiske, alicykliske og aromatiske, primære, sekundære og tertiære aminer, mettede og umettede nitrogenbaser, urinstoff, tiourinstoff og basiske ioneutvekslerharpikser. Således er alifatiske, primære aminer f.eks. metylamin, etylamin, n-butylamin, oktyl-amin, dodecylamin og heksametylen-diamin, alifatiske sekundære aminer f.eks. dimetylamin, dietylamin, di-n-propylamin og di-iso-butylamin, alifatiske tertiære aminer f.eks. trietylamin, alicykliske primære aminer f.eks. cykloheksylamin, aromatiske primære aminer f.eks. anilin, toluidin, naftylamin og benzidin, aromatiske sekundære aminer f.eks. N-metylanilin og difenylamin, aromatiske tertiære aminer f.eks. N,N-dietylanilin, mettede og umettede nitrogenbaser f.eks. heterocykliske baser, f.eks. pyrrolidin, piperidin, N-metyl-2-pyrrolidon, pyrazolidin, piperazin, pyridin, picolin, indolin, chinuclidin, morfolin, N-metylmorf olin, 1,4-diazabicyklo/-2 ,2 ,2_7-oktan og triacetonamin, urinstoff, tiourinstoff og sterke og svakt basiske ioneutvekslerharpikser. Foretrukket er også acetonin samt diacetonamin og triacetonamin. Eksempler for foretrukkede salter er: Cykloheksylamin-formiat, pyridinformiat, pyridin^p-toluensulfonat, di-n-butylaminacetat, di-n-butylamin-benzoat, morfolinsuccinat, morfolin-maleat, trietylamin-acetat, trietylamin-succinat, trietylamin-maleat, anilin-acetat, triacetonamin-p-toluensulfonat og acetonin-hydroklorid. Examples for such protonic acids or for the acid components in salts used as acid catalysts are especially mineral acids such as hydrochloric acid, hydrobromic acid, hydroiodic acid, nitric acid, sulfuric acid and phosphoric acid, as well as sulphonic acids, such as aliphatic or aromatic sulphonic acids, e.g. methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid or naphthalenesulfonic acid, phosphonic acids or phosphinic acids, such as aliphatic or aromatic, e.g. methyl, benzyl or phenylphosphonic acid, or dimethyl, diethyl or phenylphosphinic acid and carboxylic acids such as monobasic, dibasic or tribasic aliphatic or aromatic carboxylic acids, e.g. saturated or unsaturated monobasic aliphatic carboxylic acids with 1-18 C atoms, such as formic acid, acetic acid, chloroacetic acid, dichloroacetic acid, trichloroacetic acid, propionic acid, butyric acid, lauric acid, palmitic acid, stearic acid, acrylic acid, methacrylic acid and cinnamic acid, saturated and unsaturated dibasic aliphatic carboxylic acids such as oxalic acid, malonic acid, succinic acid, adipic acid, sebacic acid, tartaric acid, malic acid, fumaric acid and maleic acid, tribasic aliphatic carboxylic acids such as citric acid, monobasic aromatic carboxylic acids such as optionally substituted benzoic acids and naphthoic acids and dibasic aromatic carboxylic acids such as phthalic acid and terephthalic acid. Preferred are monobasic and dibasic, aliphatic or aromatic carboxylic acids and monobasic aromatic sulphonic acids, such as acetic acid, succinic acid, maleic acid, benzoic acid, o-iodobenzoic acid, m-methylbenzoic acid, p-tert-butylbenzoic acid, p-toluenesulphonic acid and cinnamic acid. As organic bases are suitable: aliphatic, alicyclic and aromatic, primary, secondary and tertiary amines, saturated and unsaturated nitrogen bases, urea, thiourea and basic ion exchange resins. Thus, aliphatic, primary amines are e.g. methylamine, ethylamine, n-butylamine, octylamine, dodecylamine and hexamethylenediamine, aliphatic secondary amines e.g. dimethylamine, diethylamine, di-n-propylamine and di-iso-butylamine, aliphatic tertiary amines e.g. triethylamine, alicyclic primary amines e.g. cyclohexylamine, aromatic primary amines e.g. aniline, toluidine, naphthylamine and benzidine, aromatic secondary amines e.g. N-methylaniline and diphenylamine, aromatic tertiary amines e.g. N,N-diethylaniline, saturated and unsaturated nitrogenous bases e.g. heterocyclic bases, e.g. pyrrolidine, piperidine, N-methyl-2-pyrrolidone, pyrazolidine, piperazine, pyridine, picoline, indoline, chinuclidine, morpholine, N-methylmorpholine, 1,4-diazabicyclo/-2 ,2 ,2_7-octane and triacetonamine, urea, thiourea and strong and weakly basic ion exchange resins. Acetonine as well as diacetonamine and triacetonamine are also preferred. Examples of preferred salts are: Cyclohexylamine formate, pyridine formate, pyridine^p-toluenesulfonate, di-n-butylamine acetate, di-n-butylamine benzoate, morpholine succinate, morpholine maleate, triethylamine acetate, triethylamine succinate, triethylamine maleate, aniline acetate, triacetonamine p-toluenesulfonate and acetonine hydrochloride.
Spesielt foretrukket er ammoniumklorid eller bortrifluorid eller en blanding av begge forbindelser. Particular preference is given to ammonium chloride or boron trifluoride or a mixture of both compounds.
Disse katalysatorer anvendes i en mengde fra 0,2 tilThese catalysts are used in an amount from 0.2 to
12 moll, referert til det anvendte aceton, fortrinnsvis anvender man 2-5 moll. 12 moles, referred to the acetone used, preferably 2-5 moles are used.
Som ekstra co-katalysator kan man anvende: Kaliumjodid, natriumjodid, litiumbromid, litiumjodid, litiumrodanid, ammoniumrodanid, litiumcyanid, litiumnitrat, ammoniumsulfid, brom, jod eller et bromid, jodid, nitrat, metansulfonat, benzensulfonat eller p-toluensulfonat av ammoniakk, trietylamin, urinstoff eller tiourinstoff, eksempelvis i mengder fra 0,01 til 0,5 moll referert til aceton. As an additional co-catalyst, you can use: Potassium iodide, sodium iodide, lithium bromide, lithium iodide, lithium rhodanide, ammonium rhodanide, lithium cyanide, lithium nitrate, ammonium sulphide, bromine, iodine or a bromide, iodide, nitrate, methanesulfonate, benzenesulfonate or p-toluenesulfonate of ammonia, triethylamine, urea or thiourea, for example in amounts from 0.01 to 0.5 moles referred to acetone.
Reaksjonstemperaturen utgjør i første fremgangsmåtetrinn 5 til 60°C, fortrinnsvis 5 til 35, spesielt 5 til 25°C. Fordelaktig viser det seg i første fremgangsmåtetrinn med tilsetning av en mono-eller polyfunksjonell-alkohol. Eksempler på hertil egnede alkoholer er metanol, butanol, cykloheksanol, benzylalkohol, etylenglykol, dietylenglykol, propylenglykol, etylenglykolmonoetyleter eller 2-etyl-heksanol. Fortrinnsvis anvender man lavere monoalkoholer som metanol, etanol og isopropanol, hvorav metanol er spesielt foretrukket. The reaction temperature in the first method step is 5 to 60°C, preferably 5 to 35, especially 5 to 25°C. It is advantageous in the first method step with the addition of a mono- or polyfunctional alcohol. Examples of suitable alcohols are methanol, butanol, cyclohexanol, benzyl alcohol, ethylene glycol, diethylene glycol, propylene glycol, ethylene glycol monoethyl ether or 2-ethylhexanol. Lower monoalcohols such as methanol, ethanol and isopropanol are preferably used, of which methanol is particularly preferred.
Reaksjonstiden av dette første fremgangsmåtetrinn som forløper ved lav temperatur er minst 1 fortrinnsvis 3 timer. The reaction time of this first method step, which takes place at a low temperature, is at least 1, preferably 3 hours.
En fremgangsmåtevariant er følgende:A method variant is the following:
I tilslutning til dette første fremgangsmåteåvsnitt tilsetter man til reaksjonsmediet en ytterligere mengde aceton og/ eller diacetonalkohol eller mesityloksyd eller foron eller diacetonamin eller triacetondiamin.og øker temperaturen fortrinnsvis til 40 til 65°C. I vanlig tilfelle tilsetter man herved aceton, nemlig en mengde på minst 0,5, spesielt 1 deler, fortrinnsvis 2-4 deler pr. del av den til å begynne med anvendte acetonmengde. Likeledes som aceton lar det seg anvendende ovenfor anførte acetonderivater, fortrinnsvis diacetonalkohol eller dets blanding med aceton. Videre kan det være av fordel, i dette annet fremgangsmåtetrinn til reaksjonsmediet å sette ytterligere katalysator. Dette kan foregå sammen med tilsetningen av aceton resp. acetonderivater eller også noe senere. Som katalysatorer egner det seg herved de samme stoffer som i første fremgangsmåtetrinn, spesielt egnet er bortrifluorid, ammoniumklorid, konsentrert svovelsyre eller klorhydrogen. In connection with this first method section, a further amount of acetone and/or diacetone alcohol or mesityl oxide or phorone or diacetonamine or triacetonediamine is added to the reaction medium and the temperature is preferably increased to 40 to 65°C. In the usual case, acetone is added, namely an amount of at least 0.5, especially 1 part, preferably 2-4 parts per part of the initially used amount of acetone. As well as acetone, the acetone derivatives mentioned above can be used, preferably diacetone alcohol or its mixture with acetone. Furthermore, in this second method step, it may be advantageous to add additional catalyst to the reaction medium. This can take place together with the addition of acetone or acetone derivatives or also something later. As catalysts, the same substances as in the first process step are suitable, particularly suitable are boron trifluoride, ammonium chloride, concentrated sulfuric acid or hydrogen chloride.
Reaksjonstiden som er nødvendig for annet fremgangsmåtetrinn som forløper ved forhøyet temperatur, utgjør ca. 3 til 20 timer. The reaction time required for the second method step, which takes place at an elevated temperature, amounts to approx. 3 to 20 hours.
Fordelaktig er også følgende fremgangsmåteføring for trinn b): 8-20 timer ved 50~55°C eller i første rekke 2-7 timer ved 50-55°C og deretter ytterlitere 2-6 timer ved tilbakeløpstemperatur, spesielt ved ca. 56-60°C. The following procedure is also advantageous for step b): 8-20 hours at 50~55°C or primarily 2-7 hours at 50-55°C and then a further 2-6 hours at reflux temperature, especially at approx. 56-60°C.
Ved begge fremgangsmåtetrinn kan det arbeides under trykk, f.eks. ved 1-30, spesielt 1-10, fremfor alt 1-3 atmosfærers overtrykk. I dette tilfellet er det mulig med temperaturer over 60°C. In both process steps, work can be done under pressure, e.g. at 1-30, especially 1-10, above all 1-3 atmospheres overpressure. In this case, temperatures above 60°C are possible.
Isoleringen av tetrametylpiperidonet kan foregår på i og for seg kjent måte, f.eks. ved tilsetning av vann og adskillelse som hydrat eller ved tilsetning av syre, som saltsyre, svovelsyre eller oksalsyre og adskillelse som salt eller ved tilsetning av et overr skudd av lut, spesielt konsentrert lut som vandig natronlut eller kalilut og adskillelse som organisk sjikt eller spesielt ved destillering, eventuelt etter nøytralisering av katalysatoren ved tilsetning av base, som natriumhydroksyd, kalmumhydroksyd eller natriumkarbonat. The isolation of the tetramethylpiperidone can take place in a manner known per se, e.g. by addition of water and separation as hydrate or by addition of acid, such as hydrochloric acid, sulfuric acid or oxalic acid and separation as salt or by addition of an excess of lye, especially concentrated lye such as aqueous caustic soda or potassium lye and separation as an organic layer or especially by distillation, optionally after neutralization of the catalyst by addition of a base, such as sodium hydroxide, potassium hydroxide or sodium carbonate.
Acetonet som anvendes i første trinn av fremgangsmåten kan inneholde i et visst omfang vann og/eller kondensasjonsprodukter av aceton, som diacetonalkohol, mesityloksyd, foron, diacetonamin og/eller triacetondiamin. En slik tilsetning kan virke gunstig på utbyttet. Et foretrukket kondensasjonsprodukt av aceton er mesityloksyd og spesielt diacetonalkohol. Derved er det mulig, at ved destillativ opparbeidelse ved slutten av annet trinn dannet destillat å anvende.;som råstoff i første trinn, hvilket har til følge en høy acetonomsetning. Øker reaksjonsmediets vanninnhold, f.eks. ved en slik recyklering for meget, så lønner det seg å fjerne en del av vannet fra reaksjonsblandingen. Dette kan eksempelvis foregå ved at man ved slutten av første trinn til reaksjonsblandingen setter konsentrert alkali, f.eks. natronlut, og etter kort tids omrøring adskiller det vandige sjikt. The acetone used in the first step of the method may contain to a certain extent water and/or condensation products of acetone, such as diacetone alcohol, mesityl oxide, phorone, diacetonamine and/or triacetonediamine. Such an addition can have a beneficial effect on the yield. A preferred condensation product of acetone is mesityl oxide and especially diacetone alcohol. Thereby, it is possible that during distillative processing at the end of the second step, distillate is formed to be used as raw material in the first step, which results in a high acetone turnover. Increases the water content of the reaction medium, e.g. in the case of such recycling too much, it pays to remove part of the water from the reaction mixture. This can, for example, take place by adding concentrated alkali to the reaction mixture at the end of the first step, e.g. caustic soda, and after a short period of stirring, the aqueous layer separates.
Ved fremgangsmåten ifølge oppfinnelsen kan det også anvendes organisk oppløsningsmiddel. Organisk oppløsningsmiddel som er spesielt egnet for fremgangsmåten ifølge oppfinnelsen er f.eks. hydrokarboner som aromater, f.eks. benzen, toluen og xylen samt alifatér som heksan, heptan og cykloheksan, samt klorhydrokarboner som metylenklorid, trikloretan, karbontetraklorid, kloroform, etylen-klorid og klorbenzen samt etere, som tetrahydrofuran, dioksan og dietyléter samt nitriler som acetonitril samt aprotiske polare opp-løsningsmidler som sulfolan, acetonitril, nitrometan, dimetylformamid, dimetylacetamid, tetrametylurinstoff, heksametylfosforsyreamid og dimetylsulfoksyd samt spesielt foretrukkede alkoholer som mono- eller polyfunksjonelle, usubstituerte eller substituerte alifatiske alkoholer, f.eks. lavere alkanoler som metanol, etanol, propanol, isopropanol og tert.-butanol, samt cykloheksanol, benzylalkohol, etylenglykol-monometyleter, glykol og propan-1,3-diol, fremfor alt en C-^-C^-alkohol, som metanol, som diacetonalkohol, foron, diacetonamin, triacetondiamin og mesityloksyd. Likeledes egnet er også blandinger av overnevnte oppløsningsmidler. In the method according to the invention, an organic solvent can also be used. Organic solvents that are particularly suitable for the method according to the invention are e.g. hydrocarbons such as aromatics, e.g. benzene, toluene and xylene as well as aliphatics such as hexane, heptane and cyclohexane, as well as chlorohydrocarbons such as methylene chloride, trichloroethane, carbon tetrachloride, chloroform, ethylene chloride and chlorobenzene as well as ethers such as tetrahydrofuran, dioxane and diethyl ether as well as nitriles such as acetonitrile as well as aprotic polar solvents such as sulfolane, acetonitrile, nitromethane, dimethylformamide, dimethylacetamide, tetramethylurea, hexamethylphosphoric acid amide and dimethylsulfoxide as well as particularly preferred alcohols such as mono- or polyfunctional, unsubstituted or substituted aliphatic alcohols, e.g. lower alkanols such as methanol, ethanol, propanol, isopropanol and tert.-butanol, as well as cyclohexanol, benzyl alcohol, ethylene glycol monomethyl ether, glycol and propane-1,3-diol, above all a C-^-C^-alcohol, such as methanol, such as diacetone alcohol, phorone, diacetonamine, triacetonediamine and mesityl oxide. Mixtures of the above-mentioned solvents are also suitable.
Oppfinnelsen skal forklares ved hjelp av noen eksempler: Ytterligere fordelaktige utformninger av fremgangsmåten •ifølge oppfinnelsen fremgår av på"tentkfaverie. The invention shall be explained with the help of some examples: Further advantageous designs of the method according to the invention appear from the appended claims.
Eksempel 1.Example 1.
En suspensjon, bestående av 11 g ammoniumklorid og en blanding av 340 g aceton og 64 g metanol mettes i løpet av 12 timer ved 13 til 17°C med ammoniakkgass. Deretter fortynnes den resulterende farveløse olje med 350 g aceton og holdes 15 til 20 timer under omrøring ved 50-55°C Derpå fjerner man overskytende oppløs-ningsmiddel ved fordamping i vakuum og blander'det rødlige residuet med 36 g vann. Den ved 0 til 5°C startende krystallisering avsluttes ved 2 timers omrøring. Man får 286 g 2,2,6',6-tetrametyl-4-okso-piperidinhydrat av smeltepunkt 55-60°C i form av svakt gule farvede krystaller. A suspension consisting of 11 g of ammonium chloride and a mixture of 340 g of acetone and 64 g of methanol is saturated over 12 hours at 13 to 17°C with ammonia gas. The resulting colorless oil is then diluted with 350 g of acetone and kept for 15 to 20 hours with stirring at 50-55°C. The excess solvent is then removed by evaporation in a vacuum and the reddish residue is mixed with 36 g of water. The crystallization, which starts at 0 to 5°C, ends with 2 hours of stirring. 286 g of 2,2,6',6-tetramethyl-4-oxo-piperidine hydrate of melting point 55-60°C are obtained in the form of slightly yellow colored crystals.
Man får produktet som oksalatsalt av spaltningspunkt l80°C, når man nøytraliserer reaksjonsblandingen med oksalsyre. Eksempel 2. The product is obtained as an oxalate salt with a decomposition point of 180°C, when the reaction mixture is neutralized with oxalic acid. Example 2.
Det gåes frem som angitt i eksempel 1, med den forskjell at det i annet trinn tilsettes sammen med tilsetningen av aceton 1,3 g bortrifluorid, oppløst i eter.. Isoleringen av 2,2,6,6-tetra-metyl-4-oksopiperidin foregår som angitt i eksempel 1. Proceed as indicated in example 1, with the difference that in the second step 1.3 g of boron trifluoride, dissolved in ether, is added together with the addition of acetone. The isolation of 2,2,6,6-tetra-methyl-4- oxopiperidine proceeds as indicated in example 1.
Eksempel 3»Example 3»
Det arbeides som angitt i eksempel 1, med den forskjell at det istedenfor ammoniumklorid anvendes 1,3 g brotrifluorid, oppløst i eter. I annet fremgangsmåtetrinn tilsettes deretter 11 g ammoniumklorid sammen med acetonet til reaksjonsblandingen. Work is carried out as indicated in example 1, with the difference that instead of ammonium chloride, 1.3 g of bro trifluoride, dissolved in ether, is used. In the second method step, 11 g of ammonium chloride are then added together with the acetone to the reaction mixture.
Eksempel 4- 7.Example 4-7.
En suspensjon, bestående av 11 g ammoniumklorid, 340 g aceton og 64 g metanol mettes i løpet av 4 timer ved 13 til 17°C med ammoniakkgass. Deretter fortynnes den resulterende farveløse olje med 900 g aceton og holdes 15 til 20 timer under omrøring ved 50-55°C. A suspension consisting of 11 g of ammonium chloride, 340 g of acetone and 64 g of methanol is saturated over 4 hours at 13 to 17°C with ammonia gas. The resulting colorless oil is then diluted with 900 g of acetone and kept for 15 to 20 hours with stirring at 50-55°C.
■Etter de første 6 timer dryppes det til oppløsningen i løpet av 1-2 timer 70 g 97l-ig svovelsyre. Ved slutten av reaksjonstiden innstilles reaksjonsblandingens pH-verdi med 97%-ig svovelsyre i løpet av 1-2 timer til verdien 4,5 til 5. Den dannede suspensjon av hydro-sulfatet av 2,2,6,6-tetrametyl-4-oksopiperidin filtreres ved 5-10°C og ettervaskes med aceton. Man får 655 g hydrosulfatsalt, som tilsvarer 381 g 2,2,6,6-tetrametyl-4-oksopiperidin. ■After the first 6 hours, 70 g of 97 l sulfuric acid is dripped into the solution over the course of 1-2 hours. At the end of the reaction time, the pH value of the reaction mixture is adjusted with 97% sulfuric acid over the course of 1-2 hours to the value 4.5 to 5. The formed suspension of the hydrosulphate of 2,2,6,6-tetramethyl-4- oxopiperidine is filtered at 5-10°C and washed with acetone. 655 g of the hydrosulphate salt is obtained, which corresponds to 381 g of 2,2,6,6-tetramethyl-4-oxopiperidine.
Gåes det frem som angitt ovenfor, men i annet trinn anvendes den i tabell 1 angitte mengde av aceton og svovelsyre, så If you proceed as indicated above, but in the second step the amount of acetone and sulfuric acid specified in table 1 is used, then
får man de i tabellens tredje kolonne angitte utbytter.you get the dividends stated in the third column of the table.
Eksempel 8. Example 8.
En suspensjon, bestående av 11 g ammoniumklorid, 340 g aceton og 64 g metanol mettes i løpet av 4 timer ved 13 til 17°C med ammoniakkgass. Deretter fortynnes den resulterende farveløse olje med 900 g aceton og holdes 15 til 20 timer under omrøring ved 50-55°C. Etter de første 6 timer innstilles oppløsningens pH ved innføring av ca. 23 g klorhydrogengass til 8,5-8,6. Ved slutten av reaksjonstiden innstilles reaksjonsblandingens pH-verdi med klorhydrogen i løpet av 1-2 timer til verdien 5 til 6. Den dannede suspensjon av hydroklorid av 2,2,6,6-tetrametyl-4-oksopiperidin filtreres ved 0-5°C og ettervaskes med aceton. Man får 400 g hydrokloridsalt, som tilsvarer 293 g 2,2,6,6-tetrametyl-4-oksopiperidin. A suspension consisting of 11 g of ammonium chloride, 340 g of acetone and 64 g of methanol is saturated over 4 hours at 13 to 17°C with ammonia gas. The resulting colorless oil is then diluted with 900 g of acetone and kept for 15 to 20 hours with stirring at 50-55°C. After the first 6 hours, the pH of the solution is adjusted by introducing approx. 23 g of chlorine hydrogen gas to 8.5-8.6. At the end of the reaction time, the pH value of the reaction mixture is adjusted with hydrogen chloride over the course of 1-2 hours to the value 5 to 6. The formed suspension of hydrochloride of 2,2,6,6-tetramethyl-4-oxopiperidine is filtered at 0-5°C and washed with acetone. 400 g of the hydrochloride salt is obtained, which corresponds to 293 g of 2,2,6,6-tetramethyl-4-oxopiperidine.
Fra moderluten isoleres etter avdestillering av.HgO og metanol og fortynning av destillasjonsresiduet med aceton ytterligere 95 g hydroklorid, som tilsvarer 70 g 2,2,6,6-tetrametyl-4-okso-piperidin. After distilling off HgO and methanol and diluting the distillation residue with acetone, a further 95 g of hydrochloride, which corresponds to 70 g of 2,2,6,6-tetramethyl-4-oxo-piperidine, is isolated from the mother liquor.
Eksempel 9 .Example 9.
I en blanding bestående av 126 g aceton, 22,5 g metanolIn a mixture consisting of 126 g of acetone, 22.5 g of methanol
og 4,7 g ammoniumklorid innføres 40 g ammoniakkgass i løpet av ca.and 4.7 g of ammonium chloride, 40 g of ammonia gas is introduced during approx.
4 timer ved 13-15°C. Reaksjonsblandingen omrøres deretter i 30 min-utter ved samme temperatur. Deretter tilsetter man 220 g diacetonalkohol og 110 g aceton til reaksjonsblandingen, oppvarmer det hele i løpet av 1 time ved 55°C og holder det 12 timer ved denne temperatur. Opparbeidelse av blandingen ved fraksjonert destillering gir 125 g 2,2,6,6-tetrametyl-4-oksopiperidin. Eksempel 10. 4 hours at 13-15°C. The reaction mixture is then stirred for 30 minutes at the same temperature. 220 g of diacetone alcohol and 110 g of acetone are then added to the reaction mixture, the whole is heated for 1 hour at 55°C and kept at this temperature for 12 hours. Processing of the mixture by fractional distillation yields 125 g of 2,2,6,6-tetramethyl-4-oxopiperidine. Example 10.
En suspensjon, bestående av 11 g ammoniumklorid, 340 g aceton og 64 g metanol mettes i løpet av 4 timer ved 13 til* 17°C med ammoniakkgass. Deretter fortynnes den resulterende farveløse olje med 900 g aceton og holdes 15 til 20 timer under omrøring ved 50-55°C. A suspension consisting of 11 g of ammonium chloride, 340 g of acetone and 64 g of methanol is saturated over 4 hours at 13 to* 17°C with ammonia gas. The resulting colorless oil is then diluted with 900 g of acetone and kept for 15 to 20 hours with stirring at 50-55°C.
Den dannede reaksjonsblanding inneholder i henhold til gasskromatogram 378 g 2,2,6,6-tetrametyl-4-oksopiperidin (triacetonamin) According to the gas chromatogram, the resulting reaction mixture contains 378 g of 2,2,6,6-tetramethyl-4-oxopiperidine (triacetonamine)
som isoleres ved destillering.which is isolated by distillation.
Eksempel 11.Example 11.
En suspensjon av 11 g ammoniumklorid, 340 g aceton ogA suspension of 11 g of ammonium chloride, 340 g of acetone and
4 g 20%- ig vandig oppløsning av ammoniumsulfid mettes i løpet av 4 timer ved 13 til 17°C med ammoniakkgass. Deretter går man frem som angitt i eksempel 10. 4 g of a 20% aqueous solution of ammonium sulphide is saturated within 4 hours at 13 to 17°C with ammonia gas. Then proceed as indicated in example 10.
Reaksjonsblandingen inneholder ved slutten 450 g triacetonamin . At the end, the reaction mixture contains 450 g of triacetonamine.
Eksempel 12.Example 12.
En suspensjon av 11 g ammoniumklorid, 340 g aceton ogA suspension of 11 g of ammonium chloride, 340 g of acetone and
1 g kaliumjodid mettes i løpet av 4 timer, med ammoniakkgass. Deretter går man frem som angitt i eksempel 10. Reaksjonsblandingen inneholder 400 g triacetonamin. 1 g of potassium iodide is saturated within 4 hours, with ammonia gas. Then proceed as indicated in example 10. The reaction mixture contains 400 g of triacetonamine.
Eksempel 13.Example 13.
Det gåes frem som i eksempel 10, imidlertid anvendes istedenfor 64 g metanol 64 g dioksan. Proceed as in example 10, however, instead of 64 g of methanol, 64 g of dioxane is used.
Reaksjonsblandingen inneholder 314 g triacetonamin. Eksempel 14. The reaction mixture contains 314 g of triacetonamine. Example 14.
Det gåes frem på samme måte som i eksempel 10, imidlertid blir det istedenfor 64 g metanol anvendt 64 g etanol. The procedure is the same as in example 10, however, instead of 64 g of methanol, 64 g of ethanol is used.
Reaksjonsblandingen inneholder 363 g triacetonamin. Eksempel 15. The reaction mixture contains 363 g of triacetonamine. Example 15.
Det gåes frem som i eksempel 10, imidlertid blir det istedenfor 64 g metanol anvendt 64 g isopropanol. Proceed as in example 10, however, instead of 64 g of methanol, 64 g of isopropanol is used.
Reaksjonsblandingen inneholder 350 g triacetonamin. Eksempel 16. The reaction mixture contains 350 g of triacetonamine. Example 16.
Det samme resultat som i eksempel 15 fåes når metanolen erstattes med 64 g dimetylformamid. The same result as in example 15 is obtained when the methanol is replaced by 64 g of dimethylformamide.
Eksempel 17.Example 17.
Det gåes frem som i eksempel 10, imidlertid uten metanoltilsetning. Proceed as in example 10, however without methanol addition.
Reaksjonsblandingen innholder 336 g triacetonamin. Eksempel 18. The reaction mixture contains 336 g of triacetonamine. Example 18.
En suspensjon, bestående av 11 g ammoniumklorid, 340 g aceton og 64 g metanol mettes i løpet av 4 timer ved 13 til 17°C med ' ammoniakkgass. A suspension consisting of 11 g of ammonium chloride, 340 g of acetone and 64 g of methanol is saturated over 4 hours at 13 to 17°C with ammonia gas.
Deretter fortynnes den resulterende farveløse olje med 1360 g aceton og holdes 15-20 timer under omrøring ved 50-55°C. The resulting colorless oil is then diluted with 1360 g of acetone and kept for 15-20 hours with stirring at 50-55°C.
Den dannede reaksjonsblanding inneholder 420 g triacetonamin . The resulting reaction mixture contains 420 g of triacetonamine.
Eksempel 19.Example 19.
Det gåes frem som i eksempel 10, imidlertid omrøresProceed as in example 10, but stir
etter fortynning med 900 g aceton først 6 timer ved 50-55°C og derpåafter dilution with 900 g of acetone first 6 hours at 50-55°C and then
3 timer under sterkt tilbakeløp (ved 56-60°C).3 hours under strong reflux (at 56-60°C).
Den dannede reaksjonsblanding inneholder 337 g triacetonamin . The resulting reaction mixture contains 337 g of triacetonamine.
Eksempel 20.Example 20.
Det gåes frem som i eksempel 10, imidlertid blir det istedenfor 11 g ammoniumklorid anvendt 5,5 g resp. 38 g ammoniumklorid: Proceed as in example 10, however, instead of 11 g of ammonium chloride, 5.5 g or 38 g ammonium chloride:
Claims (53)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH924173A CH574412A5 (en) | 1973-06-25 | 1973-06-25 | 2,2,6,6-Tetra-methyl-4-oxo-piperidine prepn. - from acetone and ammonia with acid catalyst in two stages with addn. of further acetone in second stage |
CH1425773 | 1973-10-05 | ||
CH543974 | 1974-04-19 | ||
CH559974 | 1974-04-24 | ||
CH701874A CH582147A5 (en) | 1974-05-22 | 1974-05-22 | 2,2,6,6-Tetra-methyl-4-oxo-piperidine prepn. - from acetone and ammonia with acid catalyst in two stages with addn. of further acetone in second stage |
Publications (1)
Publication Number | Publication Date |
---|---|
NO742255L true NO742255L (en) | 1975-01-20 |
Family
ID=27509238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO742255A NO742255L (en) | 1973-06-25 | 1974-06-20 |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPS5929589B2 (en) |
AR (1) | AR202653A1 (en) |
AT (1) | AT338262B (en) |
BG (1) | BG27080A3 (en) |
CA (1) | CA1027950A (en) |
DD (1) | DD112443A5 (en) |
DE (1) | DE2429937A1 (en) |
DK (1) | DK139678B (en) |
FI (1) | FI190574A (en) |
FR (1) | FR2234291B1 (en) |
GB (1) | GB1461703A (en) |
HU (1) | HU176761B (en) |
IE (1) | IE39523B1 (en) |
IL (1) | IL45095A (en) |
IT (1) | IT1021057B (en) |
LU (1) | LU70387A1 (en) |
NL (1) | NL190846C (en) |
NO (1) | NO742255L (en) |
SE (1) | SE403478B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2807172A1 (en) * | 1978-02-20 | 1979-08-23 | Huels Chemische Werke Ag | METHOD FOR PREPARING 2,2,6,6-TETRAMETHYLPIPERIDONE- (4) |
IT1094039B (en) * | 1978-03-31 | 1985-07-26 | Chimosa Chimica Organica Spa | PROCESS FOR THE PREPARATION OF 2,2,6,6-TETRAMETHY-4-PIPERIDONE |
US4275211A (en) * | 1978-11-17 | 1981-06-23 | Ciba-Geigy Corporation | Process for preparing 2,2,6,6-tetraalkyl-4-oxopiperidines |
DE2916471A1 (en) * | 1979-04-24 | 1980-11-06 | Hoechst Ag | Tri:acetonamine prodn. from acetone and ammonia - under defined conditions using little or no catalyst |
DE3013403A1 (en) * | 1980-04-05 | 1981-10-08 | Hoechst Ag, 6000 Frankfurt | METHOD FOR PRODUCING 2,2,6,6-TETRAMETHYLPIPERDON-4 |
DE3119514A1 (en) * | 1981-05-15 | 1983-02-24 | Empresa Cubana Exportadora e Importadora de Productos Médicos Medicuba, La Habana | Triacetoneamine hydrochloride, process for its preparation and medicaments |
JPH0739389B2 (en) * | 1986-03-03 | 1995-05-01 | 吉富製薬株式会社 | Method for producing 2,2,6,6-tetramethyl-4-oxopiperidine |
DE19634157A1 (en) * | 1996-08-23 | 1998-02-26 | Basf Ag | Process for the preparation of 2,2,6,6-tetramethylpiperidin-4-one |
DE102012215903A1 (en) | 2012-09-07 | 2014-03-13 | Evonik Industries Ag | Process for the treatment of a wastewater stream, which results from the workup of a triacetonamine-containing reaction mixture |
DE102012215900A1 (en) | 2012-09-07 | 2014-05-15 | Evonik Industries Ag | Process for the preparation and processing of a triacetonamine-containing reaction mixture |
EP3663284B1 (en) | 2018-12-07 | 2021-02-03 | Evonik Operations GmbH | Improved method for the preparation of triacetonamine |
EP3750876A1 (en) | 2019-06-13 | 2020-12-16 | Evonik Operations GmbH | Method for preparing triacetone amine, 2,2,4,6-tetramethylpiperidine and/or the salts of 2,2,4,6-tetramethylpiperidine |
US11731940B2 (en) | 2020-05-07 | 2023-08-22 | Evonik Operations Gmbh | Process for preparing triacetonamine |
EP4279484A1 (en) | 2022-05-17 | 2023-11-22 | Sabo GmbH | Improved method for the preparation of triacetonamine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3513170A (en) * | 1966-07-23 | 1970-05-19 | Sankyo Co | Preparation of 2,2,6,6-tetramethyl-4-oxopiperidine |
-
1974
- 1974-06-20 SE SE7408172A patent/SE403478B/en unknown
- 1974-06-20 FI FI1905/74A patent/FI190574A/fi unknown
- 1974-06-20 DK DK330874AA patent/DK139678B/en unknown
- 1974-06-20 NO NO742255A patent/NO742255L/no unknown
- 1974-06-21 IL IL45095A patent/IL45095A/en unknown
- 1974-06-21 DE DE2429937A patent/DE2429937A1/en active Granted
- 1974-06-21 DD DD179373A patent/DD112443A5/en unknown
- 1974-06-21 GB GB2760474A patent/GB1461703A/en not_active Expired
- 1974-06-21 LU LU70387*A patent/LU70387A1/xx unknown
- 1974-06-21 FR FR7421684A patent/FR2234291B1/fr not_active Expired
- 1974-06-21 JP JP49071215A patent/JPS5929589B2/en not_active Expired
- 1974-06-21 IT IT24300/74A patent/IT1021057B/en active
- 1974-06-21 CA CA203,059A patent/CA1027950A/en not_active Expired
- 1974-06-21 NL NL7408409A patent/NL190846C/en not_active IP Right Cessation
- 1974-06-21 AT AT517774A patent/AT338262B/en not_active IP Right Cessation
- 1974-06-21 AR AR254314A patent/AR202653A1/en active
- 1974-06-21 HU HUCI001483 patent/HU176761B/en unknown
- 1974-06-21 BG BG027040A patent/BG27080A3/en unknown
- 1974-06-21 IE IE1302/74A patent/IE39523B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR2234291A1 (en) | 1975-01-17 |
AU7043274A (en) | 1976-01-08 |
DD112443A5 (en) | 1975-04-12 |
IE39523B1 (en) | 1978-10-25 |
JPS5036473A (en) | 1975-04-05 |
NL7408409A (en) | 1974-12-30 |
GB1461703A (en) | 1977-01-19 |
DK139678B (en) | 1979-03-26 |
DE2429937C2 (en) | 1988-01-28 |
IL45095A0 (en) | 1974-09-10 |
DK330874A (en) | 1975-02-17 |
SE7408172L (en) | 1974-12-27 |
FR2234291B1 (en) | 1980-01-25 |
DK139678C (en) | 1979-09-10 |
IL45095A (en) | 1977-05-31 |
IE39523L (en) | 1974-12-25 |
HU176761B (en) | 1981-05-28 |
AT338262B (en) | 1977-08-10 |
BG27080A3 (en) | 1979-08-15 |
IT1021057B (en) | 1978-01-30 |
AR202653A1 (en) | 1975-06-30 |
FI190574A (en) | 1974-12-26 |
SE403478B (en) | 1978-08-21 |
ATA517774A (en) | 1976-12-15 |
JPS5929589B2 (en) | 1984-07-21 |
DE2429937A1 (en) | 1975-01-16 |
CA1027950A (en) | 1978-03-14 |
LU70387A1 (en) | 1976-04-13 |
NL190846C (en) | 1994-09-16 |
NL190846B (en) | 1994-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO742255L (en) | ||
EP0274379B1 (en) | Process for preparing pyridine-2,3-dicarboxylic acid compounds | |
NO742256L (en) | ||
NO135751B (en) | ||
US3959295A (en) | Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine | |
US3963730A (en) | Process for preparing triacetonamine | |
NO138338B (en) | PROCEDURE FOR THE PREPARATION OF WOODBOARD PLATES WITH CONDENSATION RESINS AS BINDER | |
US3959298A (en) | Process for preparing triacetonamine | |
US2639285A (en) | Production of thiazolylamines | |
JPS5830308B2 (en) | Triacetone amino acid | |
US20040199002A1 (en) | Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor | |
Faith et al. | Tetrahydrothiophene 1, 1-dioxide derivatives | |
NO742960L (en) | ||
US3450709A (en) | Process for the preparation of ring-substituted 2-aminoimidazoles | |
US3378592A (en) | Process for the production of 3, 4-dihydroxybenzyloxyaminehydrobromide | |
DE2924712A1 (en) | PROCESS FOR THE PREPARATION OF N-ALKYLBENZOTHIAZOLONE DERIVATIVES | |
US2086691A (en) | Process for producing amino compounds of the quinoline series | |
US3459801A (en) | Process for the manufacture of mono-halogeno-n-alkyl-acetoacetamides | |
EP0041170B1 (en) | 3-nitro-pivaloyl-acetanilides, processes for their preparation and their utilization | |
PL93316B1 (en) | ||
SU670217A3 (en) | Method of producing 2,2,6,6-tetramethyl-4-oxopiperidine | |
SU721001A3 (en) | Method of preparing 2,2,6,6-tetramethyl-4-oxopiperidine | |
JPS5843392B2 (en) | triacetone amino | |
SU843742A3 (en) | Method of preparing triacetoamine | |
DE1119290B (en) | Process for the preparation of benzene disulfonamides |